|
Insider Trading: CUTERA INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CUTERA INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of CUTERA INC since year 2005. Table 2 shows the detailed insider transactions of CUTERA INC since 2005.
The reporting company's ticker symbol is CUTR.
The reporting company's CIK number is 1162461.
The total value of stock buying since 2005 is $199,765.
The total value of stock sales is $34,939,326.
The total value of stock exercises is $1,097,909.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at CUTERA INC (CUTR) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at CUTERA INC (CUTR) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for CUTERA INC (CUTR).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2007-12 | 0 | 0 | 210,000 | 3,233,651 | 0 | 0 |
| 2007-10 | 0 | 0 | 60,000 | 1,457,215 | 0 | 0 |
| 2007-08 | 0 | 0 | 0 | 0 | 65,000 | 6,500 |
| 2007-05 | 0 | 0 | 0 | 0 | 60,000 | 6,000 |
| 2007-02 | 0 | 0 | 165,500 | 6,122,990 | 395,500 | 366,446 |
| 2006-11 | 0 | 0 | 84,291 | 2,376,641 | 81,480 | 595,763 |
| 2006-08 | 0 | 0 | 147,281 | 3,520,347 | 15,000 | 113,200 |
| 2006-06 | 0 | 0 | 0 | 0 | 100,000 | 10,000 |
| 2006-02 | 5,000 | 126,120 | 0 | 0 | 0 | 0 |
| 2005-11 | 0 | 0 | 402,481 | 14,124,077 | 0 | 0 |
| 2005-08 | 0 | 0 | 46,737 | 1,039,664 | 0 | 0 |
| 2005-07 | 0 | 0 | 16,600 | 295,317 | 0 | 0 |
| 2005-06 | 0 | 0 | 27,200 | 435,877 | 0 | 0 |
| 2005-05 | 5,000 | 73,645 | 62,800 | 999,145 | 0 | 0 |
| 2005-04 | 0 | 0 | 37,000 | 670,056 | 0 | 0 |
| 2005-03 | 0 | 0 | 36,000 | 664,346 | 0 | 0 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for CUTERA INC (CUTR)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2007-12-27 | Connors Kevin P (President and CEO) | Sale | 37,500 | 15.22 | 570,830 |
| 2007-12-27 | Gollnick David A (VP of Research and Development) | Sale | 60,000 | 15.22 | 913,500 |
| 2007-12-21 | Connors Kevin P (President and CEO) | Sale | 37,500 | 14.91 | 558,955 |
| 2007-12-14 | Connors Kevin P (President and CEO) | Sale | 37,500 | 15.02 | 563,281 |
| 2007-12-07 | Connors Kevin P (President and CEO) | Sale | 37,500 | 16.72 | 627,085 |
| 2007-10-23 | Gollnick David A (VP of Research and Development) | Sale | 30,000 | 24.46 | 733,781 |
| 2007-10-22 | Gollnick David A (VP of Research and Development) | Sale | 30,000 | 24.11 | 723,434 |
| 2007-08-20 | Connors Kevin P (President and CEO) | Option Exercise | 65,000 | .10 | 6,500 |
| 2007-05-10 | Gollnick David A (VP of Research and Development) | Option Exercise | 60,000 | .10 | 6,000 |
| 2007-02-28 | Connors Kevin P (President and CEO) | Option Exercise | 150,000 | .10 | 15,000 |
| 2007-02-27 | Connors John (VP of North American Sales) | Sale | 7,500 | 36.69 | 275,139 |
| 2007-02-27 | Connors John (VP of North American Sales) | Option Exercise | 7,500 | .75 | 5,625 |
| 2007-02-23 | Gollnick David A (VP of Research and Development) | Sale | 35,000 | 37.23 | 1,302,933 |
| 2007-02-23 | Gollnick David A (VP of Research and Development) | Option Exercise | 35,000 | .10 | 3,500 |
| 2007-02-22 | Connors Kevin P (President and CEO) | Sale | 100,000 | 37.12 | 3,712,285 |
| 2007-02-22 | Connors Kevin P (President and CEO) | Option Exercise | 100,000 | 1.29 | 128,571 |
| 2007-02-21 | Shine Robert John Jr (VP of International) | Sale | 3,000 | 37.35 | 112,055 |
| 2007-02-21 | Shine Robert John Jr (VP of International) | Option Exercise | 3,000 | 4.25 | 12,750 |
| 2007-02-20 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Sale | 10,000 | 37.06 | 370,578 |
| 2007-02-20 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Option Exercise | 10,000 | 5.50 | 55,000 |
| 2007-02-09 | Apfelberg David B (Director) | Option Exercise | 20,000 | 4.25 | 85,000 |
| 2007-02-08 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Sale | 10,000 | 35.00 | 350,000 |
| 2007-02-08 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Option Exercise | 10,000 | 5.50 | 55,000 |
| 2007-02-08 | Gollnick David A (VP of Research and Development) | Option Exercise | 60,000 | .10 | 6,000 |
| 2006-11-28 | Connors John (VP of North American Sales) | Sale | 9,917 | 27.61 | 273,790 |
| 2006-11-28 | Connors John (VP of North American Sales) | Option Exercise | 9,917 | .27 | 2,644 |
| 2006-11-14 | Oshea Timothy J (Director) | Sale | 5,000 | 28.40 | 142,000 |
| 2006-11-14 | Oshea Timothy J (Director) | Option Exercise | 5,000 | 14.14 | 70,700 |
| 2006-11-14 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Sale | 5,000 | 28.40 | 142,000 |
| 2006-11-14 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Option Exercise | 5,000 | 5.50 | 27,500 |
| 2006-11-13 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Sale | 5,000 | 28.30 | 141,500 |
| 2006-11-13 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Option Exercise | 5,000 | 5.50 | 27,500 |
| 2006-11-10 | Gollnick David A (VP of Research and Development) | Sale | 33,183 | 28.05 | 930,901 |
| 2006-11-10 | Gollnick David A (VP of Research and Development) | Option Exercise | 33,183 | 11.09 | 368,054 |
| 2006-11-09 | Shine Robert John Jr (VP of International) | Sale | 5,000 | 28.28 | 141,417 |
| 2006-11-09 | Shine Robert John Jr (VP of International) | Option Exercise | 5,000 | 4.25 | 21,250 |
| 2006-11-09 | Gollnick David A (VP of Research and Development) | Sale | 21,191 | 28.55 | 605,033 |
| 2006-11-09 | Gollnick David A (VP of Research and Development) | Option Exercise | 18,380 | 4.25 | 78,115 |
| 2006-08-31 | Connors John (VP of North American Sales) | Sale | 8,083 | 23.20 | 187,561 |
| 2006-08-29 | Oshea Timothy J (Director) | Sale | 5,000 | 23.15 | 115,757 |
| 2006-08-29 | Oshea Timothy J (Director) | Option Exercise | 5,000 | 14.14 | 70,700 |
| 2006-08-24 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Sale | 3,780 | 25.13 | 94,980 |
| 2006-08-24 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Option Exercise | 3,780 | 4.25 | 16,065 |
| 2006-08-23 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Sale | 6,220 | 25.18 | 156,630 |
| 2006-08-23 | Santilli Ronald J (CFO & VP of Finance and Admin.) | Option Exercise | 6,220 | 4.25 | 26,435 |
| 2006-08-11 | Gollnick David A (VP of Research and Development) | Sale | 20,000 | 24.10 | 480,982 |
| 2006-08-10 | Gollnick David A (VP of Research and Development) | Sale | 44,700 | 23.82 | 1,067,467 |
| 2006-06-20 | Gollnick David A (VP of Research and Development) | Option Exercise | 100,000 | .10 | 10,000 |
| 2006-02-17 | Campbell White Annette (Director) | Purchase | 3,000 | 25.50 | 76,500 |
| 2006-02-16 | Campbell White Annette (Director) | Purchase | 2,000 | 24.81 | 49,620 |
| 2005-11-23 | Liolios Thomas John (VP of International) | Sale | 742 | 39.41 | 29,242 |
| 2005-11-17 | Connors John (VP of North American) | Sale | 10,000 | 38.20 | 382,050 |
| 2005-11-08 | Connors Kevin P (President and CEO) | Sale | 70,232 | 34.97 | 2,455,872 |
| 2005-11-08 | Gollnick David A (VP of Research and D) | Sale | 59,007 | 35.33 | 2,084,599 |
| 2005-11-07 | Connors Kevin P (President and CEO) | Sale | 107,500 | 35.18 | 3,776,751 |
| 2005-11-07 | Gollnick David A (VP of Research and D) | Sale | 67,500 | 35.00 | 2,362,432 |
| 2005-11-04 | Apfelberg David B (Director) | Sale | 20,000 | 33.54 | 670,699 |
| 2005-08-25 | Connors John (VP of North American) | Sale | 7,000 | 23.10 | 161,686 |
| 2005-08-24 | Connors John (VP of North American) | Sale | 3,000 | 22.81 | 68,421 |
| 2005-08-18 | Connors Kevin P (President and CEO) | Sale | 5,000 | 21.08 | 105,399 |
| 2005-08-15 | Nohra Guy P (Director) | Sale | 1,737 | 23.33 | 40,524 |
| 2005-08-11 | Connors Kevin P (President and CEO) | Sale | 5,000 | 21.87 | 109,350 |
| 2005-08-04 | Connors Kevin P (President and CEO) | Sale | 5,000 | 21.99 | 109,949 |
| 2005-08-04 | Apfelberg David B (Director) | Sale | 5,000 | 22.00 | 110,000 |
| 2005-08-03 | Connors Kevin P (President and CEO) | Sale | 15,000 | 22.29 | 334,335 |
| 2005-07-28 | Connors Kevin P (President and CEO) | Sale | 5,000 | 18.50 | 92,500 |
| 2005-07-25 | Connors Kevin P (President and CEO) | Sale | 5,000 | 18.48 | 92,400 |
| 2005-07-11 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 16.56 | 54,654 |
| 2005-07-05 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 16.90 | 55,763 |
| 2005-06-27 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 17.70 | 58,410 |
| 2005-06-22 | Gollnick David A (VP of Research and D) | Sale | 2,000 | 17.88 | 35,760 |
| 2005-06-20 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 16.24 | 53,608 |
| 2005-06-15 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 16.25 | 65,004 |
| 2005-06-13 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 15.37 | 50,730 |
| 2005-06-08 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 14.75 | 59,000 |
| 2005-06-06 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 15.33 | 50,589 |
| 2005-06-01 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 15.69 | 62,776 |
| 2005-05-31 | Connors John (VP of North American) | Sale | 15,000 | 16.13 | 241,935 |
| 2005-05-31 | Levernier Michael J (VP of Clinical Devel) | Sale | 6,600 | 15.36 | 101,342 |
| 2005-05-25 | Campbell White Annette (Director) | Purchase | 5,000 | 14.73 | 73,645 |
| 2005-05-25 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 14.93 | 59,728 |
| 2005-05-23 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 15.20 | 50,169 |
| 2005-05-18 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 15.23 | 60,932 |
| 2005-05-16 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 15.58 | 51,430 |
| 2005-05-11 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 15.65 | 62,596 |
| 2005-05-09 | Levernier Michael J (VP of Clinical Devel) | Sale | 3,300 | 16.52 | 54,512 |
| 2005-05-04 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 17.71 | 70,840 |
| 2005-05-02 | Levernier Michael J (VP of Clinical Devel) | Sale | 2,000 | 16.85 | 33,700 |
| 2005-04-27 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 17.06 | 68,232 |
| 2005-04-25 | Levernier Michael J (VP of Clinical Devel) | Sale | 2,000 | 17.77 | 35,540 |
| 2005-04-21 | Connors Kevin P (President and CEO) | Sale | 5,000 | 17.28 | 86,410 |
| 2005-04-20 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 17.59 | 70,360 |
| 2005-04-18 | Levernier Michael J (VP of Clinical Devel) | Sale | 2,000 | 17.25 | 34,500 |
| 2005-04-14 | Connors Kevin P (President and CEO) | Sale | 5,000 | 18.01 | 90,040 |
| 2005-04-13 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 18.93 | 75,720 |
| 2005-04-11 | Levernier Michael J (VP of Clinical Devel) | Sale | 2,000 | 19.60 | 39,200 |
| 2005-04-07 | Connors Kevin P (President and CEO) | Sale | 5,000 | 19.23 | 96,150 |
| 2005-04-06 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 18.48 | 73,904 |
| 2005-03-31 | Connors Kevin P (President and CEO) | Sale | 5,000 | 19.08 | 95,385 |
| 2005-03-30 | Gollnick David A (VP of Research and D) | Sale | 4,000 | 19.02 | 76,100 |
| 2005-03-28 | Levernier Michael J (VP of Clinical Devel) | Sale | 2,000 | 18.99 | 37,980 |
| 2005-03-24 | Connors Kevin P (President and CEO) | Sale | 5,000 | 18.40 | 91,984 |
| 2005-03-23 | Gollnick David A (VP of Research and D) | Sale | 2,000 | 18.48 | 36,960 |
| 2005-03-21 | Levernier Michael J (VP of Clinical Devel) | Sale | 2,000 | 17.42 | 34,830 |
| 2005-03-17 | Connors Kevin P (President and CEO) | Sale | 5,000 | 18.56 | 92,815 |
| 2005-03-16 | Gollnick David A (VP of Research and D) | Sale | 2,000 | 18.77 | 37,540 |
| 2005-03-14 | Levernier Michael J (VP of Clinical Devel) | Sale | 2,000 | 18.68 | 37,352 |
| 2005-03-10 | Connors Kevin P (President and CEO) | Sale | 5,000 | 17.75 | 88,730 |
| 2005-03-09 | Gollnick David A (VP of Research and D) | Sale | 2,000 | 17.34 | 34,670 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of CUTERA INC (symbol CUTR,
CIK number 1162461) see
the Securities and Exchange Commission (SEC) website.
|
|
